Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Auryxia on ESA Utilization in ESRD Patients With High Ferritin & Low Transferrin Saturation: A Pilot Project

NCT03055598 is registered in ClinicalTrials.gov with Sreedhar Mandayam as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03055598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Auryxia on ESA Utilization in ESRD Patients With High Ferritin & Low Transferrin Saturation: A Pilot Project
Lead sponsor
Sreedhar Mandayam
Phase
Phase 4
Overall status
Active, not recruiting
Start date
May 11, 2017
Completion date
February 29, 2020
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, end stage renal disease